首页|珍黄胶囊联合康复新液治疗口腔溃疡临床效果观察

珍黄胶囊联合康复新液治疗口腔溃疡临床效果观察

扫码查看
目的 探究珍黄胶囊联合康复新液治疗口腔溃疡的临床效果及其不良反应发生情况.方法 回顾性收集2021年1月至2023年2月浙江中医药大学第五临床医学院(湖州市中心医院)收治的102例口腔溃疡患者临床资料,根据不同的治疗方法分成对照组(51例,采用常规疗法)和观察组(51例,在对照组用药基础上联用珍黄胶囊及康复新液).治疗7 d后对比2组患者的临床疗效,疼痛消退时间,溃疡愈合时间,溃疡面积及疼痛评分,白细胞介素-6(IL-6)及肿瘤坏死因子-α(TNF-α)水平以及不良反应发生情况.结果 观察组与对照组的治疗总有效率分别为96.08%和84.31%,差异具有统计学意义(χ2=3.991,P<0.05);观察组的疼痛消退时间[(3.69±0.38)d],溃疡愈合时间[(4.99±0.18)d],治疗后溃疡面积[(1.86±0.22)mm2]及疼痛评分[(1.12±0.23)分],均低于对照组[分别为(4.85±0.45)d,(6.34±0.22)d,(2.23±0.25)mm2,(1.95±0.45)分],差异具有统计学意义(t=14.065,33.917,7.935,11.729,P<0.05);治疗后,观察组的IL-6[(2.93±0.39)ng·L-1]和TNF-α水平[(31.26±3.31)ng·L-1],均低于对照组[分别为(4.14±0.48)ng·L-1和(34.95±3.25)ng·L-1],差异具有统计学意义(t=13.972,5.681,P<0.05);观察组的不良反应发生率(1.96%)与对照组(3.92%)的差异无统计学意义(χ2=0.343,P>0.05).结论 珍黄胶囊联合康复新液治疗口腔溃疡的临床效果良好,可较好降低机体的炎症因子水平,促进溃疡愈合,减轻患者疼痛,不良反应少,较为安全可靠.
Clinical observation of Zhenhuang capsule combined with Kangfuxin liquid in treating oral ulcer
Objective To study the clinical effect of Zhenhuang capsule combined with Kangfuxin liquid on oral ulcer.Methods Clinical data of 102 patients with oral ulcer admitted to Huzhou Central Hospital from January 2021 to February 2023 were retrospectively collected.According to different treatment methods,the patients were divided into the control group(n=51,receiving conventional therapy)and the observation group(n=51,receiving Zhenhuang capsule and Kangfuxin solution in addition to the medication in control group).All the patients in both groups were treated for 7 days.The clinical efficacy,pain resolution time,ulcer healing time before and after treatment,ulcer area and pain score,interleukin-6(IL-6)and tumor necrosis factor α(TNF-α)levels and the occurrence of adverse reactions were compared between the two groups.Results The total effective rate was 96.08%in the observation group and 84.31%in the control(χ2=3.991,P<0.05).In the observation group,the pain resolution time,ulcer healing time,ulcer area and pain score after treatment were(3.69±0.38)d,(4.99±0.18)d,(1.86±0.22)mm2 and(1.12±0.23)points,respectively.All these indexes in the observation group were lower than those of(4.85±0.45)d,(6.34±0.22)d,(2.23±0.25)mm2,(1.95±0.45)points in the control(t=14.065,33.917,7.935,11.729,all P<0.05).After treatment,the levels of IL-6 and TNF-α in the observation group were(2.93±0.39)ng·L-1 and(31.26±3.31)ng·L-1,respectively,which were lower than those of(4.14±0.48)ng·L-1 and(34.95±3.25)ng·L-1 in the control(t=13.972,5.681,both P<0.05).The adverse reaction rate was slightly lower in the observation than in the control(1.96%vs 3.92%),showing no significant difference(χ2=0.343,P>0.05).Conclusion Kangfuxin liquid combined with Zhenhuang capsule has good clinical effect in treating oral ulcer since it can better reduce the level of inflammatory factors in the body,promote ulcer healing,relieve patients'pain and has less adverse reactions.Meanwhile,this regimen is relatively safe and reliable.

Oral ulcerKangfuxin liquidZhenhuang capsuleCurative effectUlcer healing timeInflammatory factorAdverse drug reaction

陈思琦、郎淼杰

展开 >

浙江中医药大学第五临床医学院(湖州市中心医院)口腔科,湖州 313000

口腔溃疡 康复新液 珍黄胶囊 疗效 溃疡愈合时间 炎症因子 药品不良反应

2024

中国药物应用与监测
中国人民解放军总医院

中国药物应用与监测

CSTPCD
影响因子:1.983
ISSN:1672-8157
年,卷(期):2024.21(4)